eCOA Resources

31. eCOA Implementation Guidance For A Patient-Centric Experience 9/21/2022

    Historically, the patient perspective was captured during site visits, paper diaries, and questionnaires. Review today's platforms for collecting electronic clinical outcome assessments.

32. eCOA Best Practices For Crohn's And UC Trials 1/27/2025

    Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.

33. Advancing A New Framework For eCOA Success 3/16/2022

    In this webinar, learn how to outline a framework for helping you get the most out of eCOA in your studies.

34. Why The Everest Group Named Medable A Leader In eCOA 2/2/2026

    Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.

35. Simplifying ePRO Data Collection 10/4/2024

    The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.

36. Strong eCOA Provider And Linguistic Validation Expert Partner For Success 7/26/2022

    Explore the creation and implementation of the electronic versions of COAs (eCOAs) on a high priority study with a new client.

37. Building A Scalable Oncology Engine In A Dynamic Market 6/3/2026

    Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.

38. C3 Summit Recap: Shaping The Future Of eCOA/ePRO Highlights 2/10/2022

    Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.

39. 3 Tips To Support BYOD Decision-Making For eCOA Trials 6/16/2023

    Need help identifying whether Bring Your Own Device (BYOD) or Provisioned Device (PD) methods will better support the decision-making process? Read these three tips!

40. The Case For Cognitive Assessments In Phase 1 Clinical Trials 7/16/2024

    Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.